RNS Number : 2719Y
EKF Diagnostics Holdings PLC
02 March 2017
 

 

EKF Diagnostics Holdings plc

("EKF", the "Company")

 

Notice of results

Investor results presentation

 

EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed point-of-care business, announces that it will release its preliminary results for the year ended 31 December 2016 on Tuesday 21 March 2017.

 

Analyst briefing

A briefing for analysts will take place at 10am on Tuesday 21 March 2017 at the offices of N+1 Singer, One Bartholomew Lane, London EC2N 2AX. To register, please contact Walbrook PR on 020 7933 8780 or email ekf@walbrookpr.com.

 

Investor briefing

A briefing for all investors will take place on Tuesday 21 March 2017 at the London Capital Club, 15 Abchurch Lane, EC4N 7BW from 4.30pm for a 4.45pm start, and will be followed by drinks. If you would like to register for the investor presentation, please contact Walbrook PR on 020 7933 8780 or email ekf@walbrookpr.com

 

 

EKF Diagnostics Holdings plc 

www.ekfdiagnostics.com

Christopher Mills, Non-Executive Chairman

Tel: 029 2071 0570

Julian Baines, CEO 


Richard Evans, FD & COO




N+1 Singer (Nomad & Broker)

Tel: 020 7496 3000

Alex Price / Alex Laughton-Scott




Walbrook PR Limited

Tel: 020 7933 8780 or ekf@walbrookpr.com  

Paul McManus / Lianne Cawthorne

Mob: 07980 541 893 / 07584 391 303

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NORGMGGFVMLGNZM
admin Notice of Results 25621631 A Thu, 03/02/2017 - 07:00 LSE RNS Advance Notice of Results EKF